BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19720943)

  • 1. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Tershakovec AM; Veltri EP; Pasternak RC
    Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Settergren M; Rydén L; Pernow J
    Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Westerink J; Visseren FL
    Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.
    Liu PY; Liu YW; Lin LJ; Chen JH; Liao JK
    Circulation; 2009 Jan; 119(1):131-8. PubMed ID: 19075102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.
    Quarta CC; Potena L; Grigioni F; Scalone A; Magnani G; Coccolo F; Fallani F; Russo A; Branzi A
    J Heart Lung Transplant; 2008 Jun; 27(6):685-8. PubMed ID: 18503971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
    Farmer JA
    Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia].
    Sumarokov AB; Kukharchuk VV
    Ter Arkh; 2014; 86(12):107-15. PubMed ID: 25804051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of ezetimibe.
    Ashikaga H; Blumenthal RS; Jones SR
    Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
    [No Abstract]   [Full Text] [Related]  

  • 10. How to use ezetimibe as an anti-atherogenic agent via inhibition of Rho-kinase.
    Noma K; Higashi Y
    Circ J; 2012; 76(8):1836-7. PubMed ID: 22785339
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe improves endothelial function and inhibits Rho-kinase activity associated with inhibition of cholesterol absorption in humans.
    Nochioka K; Tanaka S; Miura M; Zhulanqiqige do E; Fukumoto Y; Shiba N; Shimokawa H
    Circ J; 2012; 76(8):2023-30. PubMed ID: 22640986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statin plus niacin or ezetimibe? What combination for which patients?].
    Parhofer K
    MMW Fortschr Med; 2009 Dec; 151(49-50):16. PubMed ID: 20085070
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
    Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
    Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced hype.
    Harrison DG; Brown WV; Raggi P
    Am J Cardiol; 2008 Aug; 102(3):368-9. PubMed ID: 18638604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
    Spence JD
    Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481
    [No Abstract]   [Full Text] [Related]  

  • 17. Case reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapy.
    Robins DN
    J Drugs Dermatol; 2007 Sep; 6(9):946-7. PubMed ID: 17941369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe coadministered with fenofibrate: some safety questions.
    Borja J
    Eur Heart J; 2005 Nov; 26(21):2344; author reply 2344. PubMed ID: 16123048
    [No Abstract]   [Full Text] [Related]  

  • 19. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    Michałek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 20. PANACEA or much a do about nothing: effect of a statin and ezetimibe on postprandial lipaemia and endothelial function in the metabolic syndrome.
    Chan DC; Watts GF
    Atherosclerosis; 2013 Mar; 227(1):32-4. PubMed ID: 23321395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.